Order Article Reprints

Daido W, Masuda T, Imano N, Matsumoto N, Hamai K, Iwamoto Y, Takayama Y, Ueno S, Sumii M, Shoda H, et al. Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer. Cancers. 2022; 14(24):6236. https://doi.org/10.3390/cancers14246236

Daido, Wakako, Takeshi Masuda, Nobuki Imano, Naoko Matsumoto, Kosuke Hamai, Yasuo Iwamoto, Yusuke Takayama, Sayaka Ueno, Masahiko Sumii, Hiroyasu Shoda, and et al. 2022. "Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer" Cancers 14, no. 24: 6236. https://doi.org/10.3390/cancers14246236